progesteronevitamin Dmetabolic syndromepolycystic ovary syndromePCOS
…g hormone ratio, total testosterone and AMH levels, and reduced progesterone and vitamin D concentrations (all p<0.0001). Clinical hyperandr…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 421–480 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
OCA8Daratumumab8TCE8Sunitinib8memantine8Calprotectin8Ribociclib8Dobutamine8sulfonylurea8Entinostat8Imatinib8Encorafenib8Rifapentine8SLEDAI8Canagliflozin8Dopamine8Maralixibat8Retatrutide8Bisoprolol8Daptomycin8Etanercept8DOAC8Parecoxib8Progesterone8chloroquine8Botulinum toxin8Quetiapine8Trastuzumab deruxtecan8high-intensity statin8local anaesthetic8Magnesium8mifepristone8GLP-18Albendazole8Hypertonic saline8PBS8Valproic acid8macrolides8Interleukin-68Mounjaro8Tylenol8Ursodeoxycholic acid (UDCA)8haloperidol8tenofovir alafenamide8NIVO7Bedaquiline7Glyburide7Nerandomilast7αPD-17Axi-Cel7Terlipressin7Butyrate75-ASA7IQOS7Ofatumumab7tPA7SGLT-2 Inhibitors7BsAb7Cladribine7Curcumin7
Articles mentioning drugs
10,506 articles · page 404 of 876NT-proBNPTakotsubo syndromesubarachnoid haemorrhageNational Hospital for Neurology and NeurosurgerycardiomyopathyTakotsubocardiac complications
…(URL; >140 ng/L) and 9 (4%) had levels 5-10× URL (71-140 ng/L). NT-proBNP was measured in 109 patients: 40 (37%) had peak levels >900 pg/…
94.9%
EntrestoBeta BlockersSGLT-2 Inhibitorscancer therapyQueen Elizabeth Hospitalhaematological malignancyIBM CorpEuropean Society of Cardiology
…of ACE-Inhibitors / ARBs, Beta Blockers, SGLT-2 Inhibitors, and Entresto at follow-up, compared to baseline (* = p-value < 0.05). ACE-I,…
paclitaxelcolchicine
… in stiffness induced metabolite changes, we treated VSMCs with paclitaxel and colchicine. Our analysis revealed that paclitaxel treatment…
Paclitaxel-based DCBssirolimus-based balloonsPaclitaxel-based balloonsRoyal Blackburn HospitalISRin-stent restenosisacute coronary syndromede novo coronary lesions
…ases (scoring balloons: fifteen vs. four; IVUS: sixteen vs. 4). Paclitaxel-based DCBs were used in seventy-one patients, followed by sirolimus-based …
NT-pro BNPimmunosuppressive therapiesICI myocarditisImmune checkpoint inhibitor (ICI) myocarditis
…ar hs-cTnT levels as compared to patients without LGE (p=0.33). NT-pro BNP also had no significant correlations with native myocardial T1 …
pantothenic acidlipoic acidDilated cardiomyopathyDCMvitamin supplementation
…o disease presentation. Dietary supplementation with biotin and pantothenic acid prevented premature death and improved both cardiac conduction …
furosemideinclisirancardiovascular diseaseBritish Heart FoundationCirculatory Disease
…most frequent attendance reason was for blood tests (n=297), IV furosemide administration (n=181) and review by the Heart Failure Speciali…
tocilizumabLASN01IL11Atrial fibrillationBritish Heart Foundation Clinical Research Training FellowshipAFheart failureablation
…assesses impact of IL11/6 signalling inhibitors (e.g. LASN01 or tocilizumab) in hAFbs in context of AF to dampen pro-fibrotic phenotypes of…
methotrexateIV methylprednisoloneoral prednisolonecardiac sarcoidosisheart failureCS
…ET-CT. The remaining patients received oral prednisolone and/or methotrexate therapy. Of the 20 CS patients, 8 (40%) had left ventricular (L…
BNP/NT-pro-BNPBrain Natriuretic Peptideheart failureBritish Society of Echocardiography
…TTE is indicated, highlights low yield scenarios and reinforces BNP/NT-pro-BNP (Brain Natriuretic Peptide) based pathways for suspected heart …
ivabradinefludrocortisonemidodrineEhlers Danlos Syndrome-hypermobile or Hypermobility Spectrum DisorderJoint hypermobilityPOTS
…elected cases. Tachycardic phenotypes prompted consideration of ivabradine, or low-dose beta-blockers. Across the cohort, conservative man…